Metabolism and degradation products of recombinant human insulin-like growth factor-I in lysosomes of rat kidney

References

• AULETTA M., NIELSEN, F. C. and GAMELTOFT, S., 1992, Receptor-mediated endocytosis and degradation of insulin-like growth factor I and II in neonatal rat astrocytes. Journal of Neuroscience Research, 31, 14–20.
   Google Scholar
• BAKER, E. N., BLUNDELL, T. L., CUTF1ELD, J. F., CUTF1ELD, S. M., DODSON, E. J., DODSON, G. G., HODGKIN, D. M., HUBBARD, R. E., IsAAcs, N. W., REYNOLDS, C. D., SAKABE, N. and VIJAYAN N. M. 1988, The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philosophical Transactions of the Royal Society in London. Series B: Biological Science, 319, 369–456.
   Google Scholar
• BALLARD, F. J., KNOWLES, P. E., WALTON, P. E., EDSON, K., OWENS, P. C., MOHLER, M. A. and FERRAIOLO, B. L., 1991, Plasma clearance and tissue distribution of labeled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats. Journal of Endocrinology, 128, 197–204.
   PubMed Web of Science ®Google Scholar
• BANSKOTA, N. K., CARPENTIER, J. L. and KING, G. L., 1986, Processing and release of insulin and insulin-like growth factor I by macro- and microvascular endothelial cells. Endocrinology, 119, 1904–1913.
   PubMedGoogle Scholar
• BESSEY, 0. A., LOWRY, 0. H. and BROCK, M. J., 1946, A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. Journal of Biological Chemistry, 164, 321–329. BHAUMICK, B. and BALA, R. M., 1987, Binding and degradation of insulin-like growth factors land II by rat kidney membrane. Endocrinology, 120, 1439–1448.
   Google Scholar
• CASC1ERI, M. A., Cmccm, G. G., APPLEBAUM, J., GREEN, B. G., HAYES, N. S. and BAYNE, M. L., 1989, Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors. Journal of Biological Chemistry, 264, 2199–2202.
   PubMedGoogle Scholar
• CLAUSSEN M., KUBLER, B., WENDLAND, M., NE1FER, K., SCHMIDT, B., ZAPF, J. and BRAULICE, T., 1997, Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology, 138, 3797–3803.
   Google Scholar
• Comm, R. M., HARVEY, T. S., and CAMPBELL, I. D., 1991, Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study. Biochemistry, 30, 5484–5491.
   PubMedGoogle Scholar
• DimENr, S., MARTIN, K. J. and STAHL, P. D., 1989, Cleavage of parathyroid hormone in macrophage endosomes illustrate a novel pathway for intracellular processing of proteins. Journal of Biological Chemistry, 264, 13403–13406.
   PubMedGoogle Scholar
• DUCKWORTH, W. C., 1988, Insulin degradation: mechanisms, products, and significance. Endocrine Reviews, 9, 319–345.
   PubMed Web of Science ®Google Scholar
• DUCKWORTH, W. C., HAMEL, F. G., PEAVY, D. E., LIEPNIEKS, J. J., RYAN, M. P., HERMODSON, M. A. and FRANK, B. H., 1988, Degradation products of insulin generated by hepatocytes and by insulin protease. Journal of Biological Chemistry, 263, 1826–1833.
   PubMed Web of Science ®Google Scholar
• DUCKWORTH, W. C., HAMEL, F. G., LIEPNLECKS, J., PEAVY, D., FRANK, B. and RABKIN, R., 1989, Insulin degradation products from the perfused rat kidney. American Journal of Physiology, 256, E208–214.
   PubMedGoogle Scholar
• FAWCETT, J. and RABKIN, R., 1995, The processing of insulin-like growth factor-I (IGF-I) by a cultured kidney cell line is altered by IGF-binding protein-3. Endocrinology, 136, 1340–1347.
   PubMedGoogle Scholar
• FLYVBJERG, A., NIELSEN, S., SHEIKH, M. L., JAcossEN, C., ORSKOV, H. and CHRISTENSEN, E. I., 1993, Luminal and basolateral uptake and receptor binding of IGF-I in rabbit renal proximal tubules. American Journal of Physiology, 265, F624–633.
   PubMedGoogle Scholar
• HAGOPIAN, W. A. and TAGER, H. S., 1987, Hepatic glucagon metabolism. Correlation of hormone processing by isolated canine hepatocytes with glucagon metabolism in man and in the dog. Journal of Clinical Investigation, 79, 409–417.
   PubMedGoogle Scholar
• HALBAN, P. A., 1994, Proinsulin processing in the regulated and the constitutive secretory pathway. Diabetologia, 37, S65–72.
   PubMedGoogle Scholar
• HALLIDAY, D. A., McNBL, J. D. and SCICCHITANO, R., 1993, A metabolite of substance P, 5P7-11 is involved in the pathogenesis of inflammatory joint disease. Medical Hypotheses, 40, 227–231.
   PubMedGoogle Scholar
• HAMEL, F. G., POSNER, B. I., BERGERON, J. J. M., FRANK, B. H. and DUCKWORTH, W. C., 1988, Isolation of insulin degradation products from endosomes derived from intact rat liver. journal of Biological Chemistry, 263, 6703–6708.
   Google Scholar
• HAYRY, P., MYLLARN1EMI, M., AAVIK, E., ALATALO, S., AHO, P., YILMAZ, S., RAISANEN -SOKOLOWSKI, A., COZZONE, G., JAMESON, B. A. and BASERGA, R., 1995, Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. F ASEB journal, 9, 1336–1344.
   Google Scholar
• HUA, Q. X., GOZANI, S. N., CHANCE, R. E., HOFFMANN, J. A., FRANK, B. H. and WEISS, M. A., 1995, Structure of a protein in a kinetic trap. Nature Structural Biology, 2, 129–138.
   PubMedGoogle Scholar
• KAUFMANN, J. E., IRMINGER, J. C. and HALBAN, P. A., 1995, Sequence requirements for proinsulin processing at the B-chain/C-peptide junction. Biochemical Journal, 310, 869–874.
   PubMedGoogle Scholar
• KIMURA, T., KANZAKI, Y., MATSUMOTO, Y., MANDAI, M., KUROSAKI, Y. and NAKAYAMA, T., 1994. Disposition of recombinant human insulin-like growth factor-I in normal and hypophysectomized rats. Biological and Pharmaceutical Bulletin, 17, 310–315.
   PubMed Web of Science ®Google Scholar
• KOMPELLA U. B. and LEE, V. H. L., 1991, Pharmacokinetics of peptide and protein drugs. In V. H. L. Lee (ed.), Peptide and Protein Drug Delivery (New York: Marcel Dekker), pp. 391–484.
   Google Scholar
• KOZUYA, H., MATSUURA, N., SAKAMOTO, M., MAKIN°, H., SAKAMOTO, Y., KADOWAKI, T., SUZUKI, Y., KOBAYASHI, M., AKAZAWA, Y., NOMURA, M., YOSHIMASA, Y., KASUGA, M., GOJI, K., NAGATAKI, S., OYASU, H. and ImuRA, H., 1993, Trial of insulinlike growth factor I therapy for patients with extrme insulin resistance syndromes. Diabetes, 42, 696–705.
   Google Scholar
• KREEGER, J. S. and LARSON, A. A., 1996, The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice. Journal of Pharmacology and Experimental Therapeutics, 279, 662–667.
   PubMedGoogle Scholar
• LAOUAR, A., WIETZERBIN, J. and BAUVOIS, B., 1994, Protease-catalyzed conversion of insulin-like growth factor-I and interleukin-6 into high molecular-mass species through the sequential action of hematopoietic surface-associated cathepsin G and gamma-glutamyl transpeptidase-related activities. European Journal of Biochemistry, 223, 617–624.
   PubMedGoogle Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MALY, P. and LUTHI, C., 1988, The binding sites of insulin-like growth factor I (IGF I) to type I IGF receptor and to a monoclonal antibody. Mapping by chemical modification of tyrosine residues. Journal of Biological Chemistry, 263, 7068–7072.
   PubMedGoogle Scholar
• MATSUO, N., YASUKURA, M., ETOH, Y., SASAKI, N., OKADA, S., TAJIRI, H., NOSE, 0. and NISHI, Y., 1992, Effects of FK780 (recombinant hIGF-I) on growth hormone insensitivity syndromes. Japanese Pharmacology and Therapeutics, 20, 2027–2035.
   Google Scholar
• MAUNSBACH, A. B., 1974, Isolation of kidney lysosomes. In S. Fleischer and L. Packer (eds), Methods in Enzymology (New York: Academic), vol. 31, pp. 330–339.
   Google Scholar
• OHSHITA, T. and KIDO, H., 1994, Involvement of a cystatin-a-sensitive cysteine proteinase in the degradation of native L-lactate dehydrogenase and serum albumin by rat liver or kidney lysosomes. European Journal of Biochemistry, 225, 781–786.
   PubMedGoogle Scholar
• PELL, M. E., DUCKWORTH, W. C. and PEAVY, D. E., 1986, Localization of insulin degradation products to an intracellular site in isolated rat hepatocytes. Biochemical and Biophysical Research Communications, 137, 1034–1040.
   PubMedGoogle Scholar
• SAITO, Y., YAMADA, H., NIWA, M. and UEDA, I., 1987, Production and isolation of recombinant somatomedin C. Journal of Biochemistry (Tokyo), 101, 123–134.
   PubMedGoogle Scholar
• SATO, A., NISHIMURA, S., OHKUBO, T., KYOUGOKU, Y., KOYAMA, S., KOBAYASHI, M., YASUDA, T. and KOBAYASHI, Y., 1993, Three-dimensional structure of human insulin-like growth factor-I (IGF-I) determined by 'H-NMR and distance geometry. International Journal of Peptide and Protein Research, 41, 433–440.
   PubMedGoogle Scholar
• SMEEKENS, S. P., 1993, Processing of protein precursors by a novel family of subtilisin-related mammalian endoproteases. Biotechnology (NY), 11, 182–186.
   PubMedGoogle Scholar
• TANAKA, Y., KITAO, K., HATA, T. and KIMURA, T., 1997, Kidney as an important metabolic organ for recombinant human insulin-like growth factor-I. Research Communications in Molecular Pathology and Pharmacology, 96, 267–276.
   PubMedGoogle Scholar
• TANDESKI, T. R., YEMM, R. S. and HOSSNER, K. L., 1990, Interaction of insulin-like growth factors (IGF) with isolated sheep hepatocytes. I. Binding and degradation of IGF-I. Domestic Animal Endocrinology, 7, 343–351.
   PubMedGoogle Scholar
• VELAZWUEZ, R. A., SUN, X., KURTZ, H. J. and LARSON, A. A., 1993, Possible role of the N-terminus of substance P in kanic acid-induced toxicity in rats. Brain Research, 624, 109–114.
   PubMedGoogle Scholar
• WATTIAUX, R. and DUVE, C., 1956, Tissue fraction studies 7. Release of bound hydrolases by means of triton X-100. Biochemical Journal, 63, 606–608.
   PubMed Web of Science ®Google Scholar
• Wuss, A., FRANK, B. H., KHAIT, I., PEKAR, A., HEINEY, R., SHOELSON, S. E. and NEURINGER, L. J., 1990, NR and photo-CIDNP studies of human proinsulin and prohormone processing intermediates with application to endopeptidase recognition. Biochemistry, 29, 8389–8401.
   PubMedGoogle Scholar
• WHARTON, D. C. and TZAGOLOFF, A., 1967, Cytochrome oxidase from beef heart mitochondria. In S. Fleischer and L. Packer (eds), Methods in Enzymology (New York: Academic), vol. 10, pp. 245–250.
   Google Scholar